Ergéa elevates co-founder Rolfe to group chief executive

David Rolfe

Ergéa, a European healthcare company specialising in diagnostic imaging and cancer care, has appointed David Rolfe as group CEO. He was previously CEO of Ergéa UK and Mark Graves now steps into this role from his position as director of operations at Ergéa UK.

Rolfe brings more than 20 years of healthcare leadership experience and is a co-founder of two businesses that later merged with others to form the foundation of Ergéa UK. Under his leadership, Ergéa will strengthen alignment between group and regional operations, accelerate its expansion into new markets, and continue to invest in cutting-edge medical technologies.

Graves has played a central role in advancing Ergéa UK’s operational excellence programme and supporting its recent growth. Before joining Ergéa UK in 2022, he held senior roles at Getinge, Johnson & Johnson, Olympus and GE HealthCare.

Read this report on page 12 of the January 2026 issue of RAD Magazine.

The content on this page is provided by the individuals concerned and does not represent the views or opinions of RAD Magazine.

Want to be featured here or know someone who should be?

For more information and to submit your piece please contact katherine@radmagazine.com